Impact of rotavirus vaccination on epidemiological dynamics in England and Wales (Q50156986)

26 February 2018

title

Impact of rotavirus vaccination on epidemiological dynamics in England and Wales (English)

1 reference

26 February 2018

Virginia E Pitzer

3

0 references

Alison P. Galvani

series ordinal

4

object named as

Alison P Galvani

1 reference

26 February 2018

Katherine E Atkins

1

1 reference

26 February 2018

Eunha Shim

series ordinal

2

1 reference

26 February 2018

language of work or name

English

0 references

publication date

28 November 2011

1 reference

26 February 2018

published in

Vaccine

1 reference

26 February 2018

volume

30

1 reference

26 February 2018

issue

3

1 reference

26 February 2018

page(s)

552-564

1 reference

26 February 2018

Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

Projected cost-effectiveness of rotavirus vaccination for children in Asia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

Cost-effectiveness of rotavirus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

Rotavirus infections and vaccines: burden of illness and potential impact of vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

Modelling the seasonality of rotavirus disease and the impact of vaccination in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

A mathematical model of the indirect effects of rotavirus vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

Dynamic model of rotavirus transmission and the impact of rotavirus vaccination in Kyrgyzstan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

Rotavirus infection in infants as protection against subsequent infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

An age-structured model for pertussis transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

Longitudinal study of rotavirus infections among children from Belém, Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

Rotavirus-specific T-cell responses in young prospectively followed-up children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

Cost-effectiveness and potential impact of rotavirus vaccination in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

RotaTeq, a pentavalent rotavirus vaccine: efficacy and safety among infants in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

Sustained efficacy of the pentavalent rotavirus vaccine, RV5, up to 3.1 years following the last dose of vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

Asymptomatic rotavirus infections in England: prevalence, characteristics, and risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

Real-world impact of rotavirus vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

Rotavirus vaccines in Belgium: policy and impact

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.064

10.1016/J.VACCINE.2011.11.064

7 January 2021

Identifiers

DOI

1 reference

26 February 2018

1 reference

26 February 2018